| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |